STOCK TITAN

PolyPid (PYPD) holder AIGH Capital discloses 9.8% beneficial share stake

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

PolyPid Ltd. received an amended Schedule 13G showing that investment manager AIGH Capital Management LLC and Orin Hirschman beneficially own 1,793,117 ordinary shares, representing 9.8% of the class. They report sole voting and dispositive power over these shares.

The filing notes that this ownership percentage excludes 2,395,268 common shares issuable upon exercise of warrants that are not currently exercisable due to beneficial ownership limits, and 549,141 shares held in abeyance. The holders state the shares were acquired and are held in the ordinary course of business and not for the purpose of influencing control of PolyPid.

Positive

  • None.

Negative

  • None.

Insights

AIGH and Orin Hirschman report a 9.8% passive stake in PolyPid.

AIGH Capital Management LLC and Orin Hirschman disclose beneficial ownership of 1,793,117 PolyPid ordinary shares, equal to 9.8% of the class. They have sole voting and dispositive power over these shares, indicating concentrated decision authority for this holding.

The filing also describes additional exposure through 2,395,268 common shares underlying warrants and 549,141 shares held in abeyance, which are excluded from current beneficial ownership due to limitations on exercising the warrants. This suggests potential future share exposure if conditions change.

The investors certify that the position was acquired and is held in the ordinary course of business, not to change or influence control. Subsequent ownership reports may show whether this stake grows above or falls below current levels, but no forward intentions are stated in the excerpt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G





SCHEDULE 13G



Orin Hirschman
Signature:Orin Hirschman
Name/Title:Orin Hirschman
Date:01/30/2026
AIGH Capital Management LLC
Signature:Orin Hirschman
Name/Title:Orin Hirschman, Managing Member
Date:01/30/2026

FAQ

What ownership stake does AIGH Capital report in PolyPid (PYPD)?

AIGH Capital Management LLC and Orin Hirschman report beneficial ownership of 1,793,117 PolyPid ordinary shares, representing 9.8% of the outstanding class. They hold sole voting and dispositive power over these shares according to the amended Schedule 13G.

Who are the reporting persons in this PolyPid (PYPD) Schedule 13G/A?

The filing is jointly made by AIGH Capital Management LLC, AIGH Investment Partners LLC, and Orin Hirschman. Hirschman is the managing member of AIGH Capital Management and president of AIGH Investment Partners, and they are collectively referred to as the reporting persons.

Does the PolyPid (PYPD) Schedule 13G/A indicate a control-seeking intent?

No. The reporting persons certify the securities were acquired and are held in the ordinary course of business and not for changing or influencing control of PolyPid. They also state the position is not part of any control-related transaction.

Are there additional PolyPid (PYPD) shares related to warrants in this filing?

Yes. The filing notes 2,395,268 common shares issuable upon warrant exercise and 549,141 shares held in abeyance. These are excluded from beneficial ownership because the warrants are not currently exercisable due to ownership limitations.

What type of securities are covered in this PolyPid (PYPD) Schedule 13G/A?

The filing covers Ordinary Shares, no par value, of PolyPid Ltd. It specifies the class using the company’s ordinary shares and identifies them with CUSIP number M8001Q126 in the ownership disclosure.

What percentage threshold does the PolyPid (PYPD) position exceed in this filing?

The reporting persons disclose ownership of 9.8% of PolyPid’s ordinary shares. This exceeds the 5% ownership reporting threshold that requires a Schedule 13G filing for certain institutional and passive investors under SEC rules.

Polypid Ltd.

NASDAQ:PYPD

PYPD Rankings

PYPD Latest News

PYPD Latest SEC Filings

PYPD Stock Data

78.35M
13.25M
16.7%
41.2%
0.22%
Biotechnology
Healthcare
Link
Israel
Petah Tikva